160 related articles for article (PubMed ID: 32985597)
1. Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro.
Celentano A; Yiannis C; Paolini R; Zhang P; Farah CS; Cirillo N; Yap T; McCullough M
Sci Rep; 2020 Sep; 10(1):15904. PubMed ID: 32985597
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of kava constituents in an in vitro model of oral mucositis.
Yiannis C; Huang K; Tran AN; Zeng C; Dao E; Baselyous O; Mithwani MA; Paolini R; Cirillo N; Yap T; McCullough M; Celentano A
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1801-1811. PubMed ID: 32435894
[TBL] [Abstract][Full Text] [Related]
3. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
Tang Y; Fields C
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
[TBL] [Abstract][Full Text] [Related]
4. Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.
Pinner KD; Wales CT; Gristock RA; Vo HT; So N; Jacobs AT
Pharm Biol; 2016 Sep; 54(9):1503-12. PubMed ID: 26789234
[TBL] [Abstract][Full Text] [Related]
5. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Abdullah MP; Ho CL; Omar AR; Ismail J; Alitheen NB
BMC Complement Altern Med; 2016 Feb; 16():86. PubMed ID: 26922065
[TBL] [Abstract][Full Text] [Related]
6. The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B.
Rossette MC; Moraes DC; Sacramento EK; Romano-Silva MA; Carvalho JL; Gomes DA; Caldas H; Friedman E; Bastos-Rodrigues L; De Marco L
Phytother Res; 2017 Oct; 31(10):1607-1613. PubMed ID: 28816367
[TBL] [Abstract][Full Text] [Related]
7. The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review.
Celentano A; Tran A; Testa C; Thayanantha K; Tan-Orders W; Tan S; Syamal M; McCullough MJ; Yap T
J Oral Pathol Med; 2019 Aug; 48(7):510-529. PubMed ID: 31172600
[TBL] [Abstract][Full Text] [Related]
8. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
Anke J; Fu S; Ramzan I
Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
[TBL] [Abstract][Full Text] [Related]
9. Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis.
Ji T; Lin C; Krill LS; Eskander R; Guo Y; Zi X; Hoang BH
Mol Cancer; 2013 Jun; 12():55. PubMed ID: 23764122
[TBL] [Abstract][Full Text] [Related]
10. Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Zulfadli AJ; Omar AR; Sulaiman MR; Abdullah MP; Alitheen NB
PLoS One; 2014; 9(10):e105244. PubMed ID: 25286005
[TBL] [Abstract][Full Text] [Related]
11. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
[TBL] [Abstract][Full Text] [Related]
12. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
Zi X; Simoneau AR
Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
Uebelhack R; Franke L; Schewe HJ
Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
[TBL] [Abstract][Full Text] [Related]
14. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.
Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB
Drug Des Devel Ther; 2015; 9():1401-17. PubMed ID: 25834398
[TBL] [Abstract][Full Text] [Related]
15. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
[TBL] [Abstract][Full Text] [Related]
16. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents.
Backhauss C; Krieglstein J
Eur J Pharmacol; 1992 May; 215(2-3):265-9. PubMed ID: 1396990
[TBL] [Abstract][Full Text] [Related]
17. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
[TBL] [Abstract][Full Text] [Related]
18. Kava does not display metabolic toxicity in a homogeneous cellular assay.
Zou L; Harkey MR; Henderson GL; Dike LE
Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141
[TBL] [Abstract][Full Text] [Related]
19. Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.
Zou L; Henderson GL; Harkey MR; Sakai Y; Li A
Phytomedicine; 2004; 11(4):285-94. PubMed ID: 15185840
[TBL] [Abstract][Full Text] [Related]
20. Flavokawain B induces apoptosis of human oral adenoid cystic cancer ACC-2 cells via up-regulation of Bim and down-regulation of Bcl-2 expression.
Zhao X; Chao YL; Wan QB; Chen XM; Su P; Sun J; Tang Y
Can J Physiol Pharmacol; 2011 Dec; 89(12):875-83. PubMed ID: 22115332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
